NASDAQ · FBLG
FibroBiologics, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for FBLG has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.63 | $-0.63 | $-0.63 | 1 |
| Dec 2026 | $-0.63 | $-0.63 | $-0.63 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Fintel- RTTNews · Sep 30, 5:32 AM EDTFibroBiologics Secures European Patent For Fibroblast Therapeutic Technology; Stock Up(RTTNews) – FibroBiologics, Inc. (FBLG), a clinical-stage biotechnology company, announced that the European Patent Office has granted European Patent No. 3568465, titled "Methods of Enhancing Fibroblast Therapeutic Activity," covering its fibroblast therapeutic technology.
- RTTNews · Sep 17, 10:06 AM EDTFibroBiologics Secures $0.5 Mln Private Placement; Stock Up(RTTNews) – FibroBiologics, Inc. (FBLG), a clinical-stage biotechnology company, announced the closing of a private placement on September 15, 2026, with Hamid Khoja, Chief Scientific Officer of FibroBiologics, who purchased 0.298 million shares and accompanying warrants to purch
- RTTNews · Sep 3, 11:09 AM EDTFibroBiologics Secures U.S. Patent For Fibroblast-Based Wound Healing Therapy; Stock Down(RTTNews) – FibroBiologics, Inc. (FBLG) announced that the U.S. Patent and Trademark Office has issued Patent No. 12,721,866 covering the therapeutic use of fibroblasts and fibroblast-derived materials for wound healing.
- RTTNews · Aug 19, 5:27 AM EDTFibroBiologics Reports Cartilage Repair In Preclinical Study Using Chondrocyte Spheroids(RTTNews) – FibroBiologics, Inc. (FBLG), a clinical-stage biotechnology company focused on fibroblast-based therapies, announced promising preclinical results showing cartilage repair in degenerative joints following a single injection of chondrocyte spheroids.
- RTTNews · May 5, 3:52 AM EDTFibroBiologics Reports Positive Preclinical Results For HDF Spheroids In Treating Burn Wounds(RTTNews) – FibroBiologics Inc. (FBLG), a clinical-stage biotechnology company, on Monday announced positive preclinical results for the topical use of human dermal fibroblast spheroids in treating burn wounds.
- RTTNews · May 4, 11:40 AM EDTFibroBiologics Releases CYWC628 Batch For Phase 1/2 Trial To Treat Diabetic Foot Ulcers(RTTNews) – FibroBiologics Inc. (FBLG), a clinical-stage biotechnology company, on Monday released the first batch of the CYWC628 drug product for the Phase 1/2 clinical trial to treat diabetic foot ulcers (DFUs).
- Fintel · Apr 8, 8:21 PM EDTFibroBiologics (FBLG) Price Target Increased by 1,584.21% to 81.60The average one-year price target for FibroBiologics (NasdaqCM:FBLG) has been revised to $81.60 / share. This is an increase of 1,584.21% from the prior estimate of $4.84 dated March 25, 2026. The price target is an average of many targets provided by analysts
- RTTNews · Apr 1, 5:30 AM EDTFibroBiologics Completes CYWC628 Manufacturing And Prices $3 Million Offering(RTTNews) – FibroBiologics, Inc., (FBLG) marked a key step forward in its diabetic foot ulcer (DFU) program with the successful manufacturing of its first CYWC628 drug- product-batch-timed the same day the company priced a $3 million public offering to support ongoing operations
- RTTNews · Mar 2, 11:40 AM ESTFibroBiologics Jumps 22% On New Osteoporosis Patent, Stock Up(RTTNews) – Shares of FibroBiologics, Inc. (FBLG) are up by 22% following the announcement that the company has been granted a new U.S. patent covering fibroblast cell therapy for the treatment of osteoporosis.
- RTTNews · Jan 12, 10:20 PM ESTAfter-Hours Biotech Rally: FBLG, NYXH, FBIO, RVTY, OPCH, ATNM, DSGN Climb On Earnings And Momentum(RTTNews) – Several biotech and healthcare names posted notable gains in Monday's after-hours trading session, with moves driven by earnings updates, guidance announcements, and broader investor sentiment.
- Fintel · Nov 20, 2:56 PM ESTD. Boral Capital Maintains FibroBiologics (FBLG) Buy RecommendationFintel reports that on November 20, 2025, D. Boral Capital maintained coverage of FibroBiologics (NasdaqCM:FBLG) with a Buy recommendation. Analyst Price Forecast Suggests 2,490.71% Upside
- RTTNews · Nov 9, 11:12 PM ESTAfter-Hours Biotech Watch: IFRX, ABCL, RLYB Among Notable Risers(RTTNews) – Several biotechnology and pharmaceutical stocks showed notable price increases during Friday's after-hours trading session, with movement driven by upcoming data releases, recent earnings reports, and prior corporate updates.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for FibroBiologics, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.